Cogent Biosciences, Inc. (COGT)

NASDAQ: COGT · Real-Time Price · USD

Compare

36.53

-0.19 (-0.52%)

At close: Feb 13, 2026, 4:00 PM EST

36.75

+0.22 (0.60%)

After-hours: Feb 13, 2026, 7:59 PM EST

Cogent Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	125.3	98.17	53.23	139.89	219.68	242.19
Short-Term Investments	265.59	188.91	212.48	119.39	-	-
Cash & Short-Term Investments	390.89	287.08	265.71	259.28	219.68	242.19
Cash Growth	16.50%	8.04%	2.48%	18.02%	-9.29%	547.15%
Prepaid Expenses	6.35	9.4	5.06	4.44	2.95	2.72
Restricted Cash	-	-	-	1.26	-	-
Total Current Assets	397.24	296.47	270.77	264.97	222.63	244.91
Property, Plant & Equipment	23.87	26.56	30.34	31.1	4.48	4.75
Long-Term Investments	-	-	7.46	-	-	-
Other Long-Term Assets	4.82	4.86	4.86	4.75	4.98	1.26
Total Assets	425.93	327.9	313.44	300.81	232.09	250.92
Accounts Payable	16.03	12.01	10.66	5.84	3.48	0.73
Accrued Expenses	43.23	41.76	25.69	17.48	7.98	4.47
Current Portion of Leases	1.71	1.57	1.39	1.42	2.32	2.05
Other Current Liabilities	1.29	0.37	0.44	2.1	3.3	5.84
Total Current Liabilities	62.25	55.71	38.17	26.85	17.08	13.09
Long-Term Leases	14.6	15.9	17.47	18.23	0.83	3.16
Other Long-Term Liabilities	2.37	-	-	-	-	-
Total Liabilities	123.47	71.61	55.64	45.08	17.91	16.25
Common Stock	0.14	0.11	0.09	0.07	0.04	0.03
Additional Paid-In Capital	1,280	1,005	801.06	601.15	399.71	322.45
Retained Earnings	-1,086	-859.48	-603.62	-411.21	-270.97	-198.7
Comprehensive Income & Other	0.21	0.45	0.25	-0.1	-	-
Total Common Equity	194.55	145.69	197.77	189.91	128.78	123.79
Shareholders' Equity	302.46	256.29	257.8	255.74	214.18	234.67
Total Liabilities & Equity	425.93	327.9	313.44	300.81	232.09	250.92
Total Debt	60.56	17.47	18.85	19.65	3.16	5.21
Net Cash (Debt)	330.33	269.61	254.32	239.63	216.53	236.98
Net Cash Growth	0.80%	6.01%	6.13%	10.67%	-8.63%	654.91%
Net Cash Per Share	2.77	2.59	3.19	4.07	5.59	21.39
Filing Date Shares Outstanding	142.45	110.54	103.91	69.95	45.81	37.19
Total Common Shares Outstanding	139.9	110.54	86.12	69.89	43.81	32.35
Working Capital	335	240.76	232.6	238.12	205.56	231.82
Book Value Per Share	1.39	1.32	2.30	2.72	2.94	3.83
Tangible Book Value	194.55	145.69	197.77	189.91	128.78	123.79
Tangible Book Value Per Share	1.39	1.32	2.30	2.72	2.94	3.83
Machinery	-	10.08	9.54	6.93	1.21	0.14
Construction In Progress	-	0.04	0.03	0.48	0.65	-
Leasehold Improvements	-	2.46	2.44	1.78	0.41	0.41

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q